EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss

Erin R Cullen iD, Mona Safari, Isabelle Mittelstadt, Matthew C Weston iD

eLife · 2024

DOI: 10.7554/elife.91323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Erin R Cullen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Sciences, Larner College of Medicine, University of Vermont, Burlington, United States. Hauptthemen laut MEDLINE: Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene variants that hyperactivate PI3K-mTOR signaling in the brain lead to epilepsy and cortical malformations in humans. Some gene variants associated with these pathologies only hyperactivate mTORC1, but others, such as PTEN , PIK3CA , and AKT , hyperactivate both mTORC1- and mTORC2-dependent signaling. Previous work established a key role for mTORC1 hyperactivity in mTORopathies, however, whether mTORC2 hyperactivity contributes is not clear. To test this, we inactivated mTORC1 and/or mTORC2 downstream of early Pten deletion in a new mouse model of somatic Pten loss-of-function (LOF) in the cortex and hippocampus. Spontaneous seizures and epileptiform activity persisted despite mTORC1 or mTORC2 inactivation alone, but inactivating both mTORC1 and mTORC2 simultaneously normalized brain activity. These results suggest that hyperactivity of both mTORC1 and mTORC2 can cause epilepsy, and that targeted therapies should aim to reduce activity of both complexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyAnimalsHumansMiceBrainCerebral CortexMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2PTEN Phosphohydrolase

Stichwörter der Autor:innen

EEGepilepsyfocalmTORmouseneurosciencesomatic

Substanzen

Mechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2PTEN PhosphohydrolasePTEN protein, humanPten protein, mouse

Autor:innen und Institutionen

  • Department of Neurological Sciences, Larner College of Medicine, University of Vermont, Burlington, United States.
  • Fralin Biomedical Research Institute at VTC, Center for Neurobiology Research, Roanoke, United States.
  • Translational Biology, Medicine, and Health Graduate Program, Roanoke, United States.
  • School of Neuroscience, Virginia Polytechnic and State University, Blacksburg, United States.

ORCID-Profile: Erin R Cullen, Matthew C Weston

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • NINDS

Zitieren

APA

Cullen, E. R., Safari, M., Mittelstadt, I., & Weston, M. C. (2024). Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss. eLife. https://doi.org/10.7554/elife.91323

Vancouver

Cullen ER, Safari M, Mittelstadt I, Weston MC. Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss. eLife. 2024. doi:10.7554/elife.91323

BibTeX
@article{Cullen2024,
  author = {Cullen, Erin R and Safari, Mona and Mittelstadt, Isabelle and Weston, Matthew C},
  title = {Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.91323}
}
Kostenlos starten →